Please use this identifier to cite or link to this item:
Title: AT2-receptor stimulation enhances axonal plasticity after spinal cord injury by upregulating BDNF expression
Authors: Namsolleck, Pawel
Boato, Francesco
Schwengel, Katja
Paulis, Ludovit
Matho, Katherine S.
GEURTS, Nathalie 
Thoene-Reineke, Christa
Lucht, Kristin
Seidel, Kerstin
Hallberg, Anders
Dahlof, Bjorn
Unger, Thomas
Steckelings, U. Muscha
Issue Date: 2013
Source: NEUROBIOLOGY OF DISEASE, 51, p. 177-191
Abstract: It is widely accepted that the angiotensin AT2-receptor (AT2R) has neuroprotective features. In the present study we tested pharmacological AT2R-stimulation as a therapeutic approach in a model of spinal cord compression injury (SCI) in mice using the novel non-peptide AT2R-agonist, Compound 21 (C21). Complementary experiments in primary neurons and organotypic cultures served to identify underlying mechanisms. Functional recovery and plasticity of corticospinal tract (CST) fibers following SCI were monitored after application of C21 (0.3 mg/kg/day i.p.) or vehicle for 4 weeks. Organotypic co-culture of GFP-positive entorhinal cortices with hippocampal target tissue served to evaluate the impact of C21 on reinnervation. Neuronal differentiation, apoptosis and expression of neurotrophins were investigated in primary murine astrocytes and neuronal cells. C21 significantly improved functional recovery after SCI compared to controls, and this significantly correlated with the increased number of CST fibers caudal to the lesion site. In vitro, C21 significantly promoted reinnervation in organotypic brain slice co-cultures (+50%) and neurite outgrowth of primary neurons (+25%). C21-induced neurite outgrowth was absent in neurons derived from AT2R-KO mice. In primary neurons, treatment with C21 further induced RNA expression of anti-apoptotic Bcl-2 (+75.7%), brain-derived neurotrophic factor (BDNF) (+53.7%), the neurotrophin receptors TrkA (+57.4%) and TrkB (+67.9%) and a marker for neurite growth, GAP43 (+103%), but not TrkC. Our data suggest that selective AT2R-stimulation improves functional recovery in experimental spinal cord injury through promotion of axonal plasticity and through neuroprotective and anti-apoptotic mechanisms. Thus, AT2R-stimulation may be considered for the development of a novel therapeutic approach for the treatment of spinal cord injury.
Notes: [Namsolleck, Pawel; Schwengel, Katja; Paulis, Ludovit; Thoene-Reineke, Christa; Lucht, Kristin; Seidel, Kerstin; Unger, Thomas; Steckelings, U. Muscha] Charite, Inst Pharmacol, Cardiovasc Res Ctr, D-10115 Berlin, Germany. [Boato, Francesco; Geurts, Nathalie; Hendrix, Sven] Hasselt Univ, Dept Morphol, BE-3590 Diepenbeek, Belgium. [Boato, Francesco; Geurts, Nathalie; Hendrix, Sven] Hasselt Univ, Inst Biomed, BE-3590 Diepenbeek, Belgium. [Matho, Katherine S.] Univ Paris 06, Inst Vis, Paris, France. [Thoene-Reineke, Christa] Charite, FEM, D-10115 Berlin, Germany. [Hallberg, Anders] Uppsala Univ, Dept Med Chem, S-75123 Uppsala, Sweden. [Dahlof, Bjorn] Sahlgrens Univ Hosp, S-41345 Gothenburg, Sweden. [Namsolleck, Pawel; Unger, Thomas] Maastricht Univ, CARIM, Maastricht, Netherlands.
Keywords: Neurosciences; angiotensin; AT2-receptor; spinal cord injury; new therapies;Angiotensin; AT2-receptor; Spinal cord injury; New therapies
Document URI:
ISSN: 0969-9961
e-ISSN: 1095-953X
DOI: 10.1016/j.nbd.2012.11.008
ISI #: 000314627100020
Category: A1
Type: Journal Contribution
Validations: ecoom 2014
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
AT2-receptor stimulation.pdf
  Restricted Access
1.69 MBAdobe PDFView/Open    Request a copy
Show full item record


checked on Sep 2, 2020


checked on May 13, 2022

Page view(s)

checked on May 19, 2022


checked on May 19, 2022

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.